Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Capricor Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Capricor Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Krasney Karen | EVP, GENERAL COUNSEL | 30,547 | Jun 29, 2026 | 6 |
| Bergmann Anthony | CHIEF FINANCIAL OFFICER | 11,223 | Jun 29, 2026 | 6 |
| Maurer Michael T | CHIEF COMMERCIAL OFFICER | – | May 28, 2026 | 1 |
| Litvack Frank | Director | 133,776 | May 14, 2026 | 2 |
| Sabar Karimah Es | Director | 0 | Apr 3, 2026 | 3 |
| Dunbar George W Jr | Director | 14,306 | Jan 7, 2026 | 2 |
| Musket David B | Director | 81,692 | Jan 7, 2026 | 1 |
| Marban Linda | CHIEF EXECUTIVE OFFICER | 211,104 | Jan 7, 2026 | 1 |
| Gotwals Philip J | Director | – | Jan 7, 2026 | 1 |
| Auwaerter Paul Gisbert | Director | 5,000 | Jan 7, 2026 | 1 |
| Kelliher Mike | Director | – | Jan 7, 2026 | 1 |
| Collier Earl M Jr | Director | 57,606 | Feb 28, 2025 | 0 |
| Nippon Shinyaku Co Ltd | 10% Owner | 7,090,351 | Sep 24, 2024 | 0 |
| Avat Xavier | Other: Former CBO | 0 | Apr 27, 2023 | 0 |
| Manzo Louis | Director | 62,147 | Feb 23, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 (view filing) | Jun 25 | 4 days | Bergmann AnthonyCHIEF FINANCIAL OFFICER | SSale | −24.1K | $30.38 | −$732.2K | −68.2%11.2K after | |
| Jun 29, 2026 (view filing) | Jun 25 | 4 days | Krasney KarenEVP, GENERAL COUNSEL | SSale | −24.1K | $30.38 | −$732.2K | −44.1%30.5K after | |
| Jun 24, 2026 (view filing) | Jun 22-24 | 2 days | Bergmann AnthonyCHIEF FINANCIAL OFFICER | SSale | −900 | $30.00 | −$27.0K | −7.4%11.2K after | 2 lots |
| Jun 24, 2026 (view filing) | Jun 22-24 | 2 days | Krasney KarenEVP, GENERAL COUNSEL | SSale | −900 | $30.00 | −$27.0K | −2.9%30.5K after | 2 lots |
| May 4, 2026 (view filing) | May 1 | 3 days | Bergmann AnthonyCHIEF FINANCIAL OFFICER | SSale | −25.0K | $31.70 | −$792.5K | −75.2%8.22K after | 10b5-1 |
| May 4, 2026 (view filing) | May 1 | 3 days | Krasney KarenEVP, GENERAL COUNSEL | SSale | −25.0K | $31.70 | −$792.5K | −45.0%30.5K after | 10b5-1 |
| Apr 3, 2026 (view filing) | Apr 2 | 1 day | Sabar Karimah EsDirector | SSale | −7.53K | $32.00 | −$240.9K | −100.0%0 after | 10b5-1 |
| Apr 1, 2026 (view filing) | Mar 31-Apr 1 | 1 day | Sabar Karimah EsDirector | SSale | −115.0K | $30.57 | −$3.52M | −100.0%0 after | 2 lots10b5-1 |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Bergmann AnthonyCHIEF FINANCIAL OFFICER | SSale | −25.0K | $30.13 | −$753.3K | −75.2%8.22K after | 10b5-1 |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Krasney KarenEVP, GENERAL COUNSEL | SSale | −25.0K | $30.12 | −$753.0K | −45.0%30.5K after | 10b5-1 |
| Sep 24, 2024 (view filing) | Sep 20 | 4 days | Nippon Shinyaku Co Ltd10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +2.80M | $5.36 | +$15.0M | +65.2%7.09M after | |
| Oct 13, 2023 (view filing) | Oct 12 | 1 day | Musket David BDirector | PPurchase | +410 | $2.75 | +$1.13K | +1.3%31.5K after | |
| Oct 12, 2023 (view filing) | Oct 10 | 2 days | Collier Earl M JrDirector | PPurchase | +10.0K | $2.83 | +$28.3K | +59.3%26.9K after | |
| Oct 11, 2023 (view filing) | Oct 9 | 2 days | Musket David BDirector | PPurchase | +5.08K | $2.82 | +$14.3K | +19.5%31.1K after | |
| Oct 10, 2023 (view filing) | Oct 6 | 4 days | Auwaerter Paul GisbertDirector | PPurchase | +5.00K | $2.84 | +$14.2K | New position5.00K after | |
| Oct 6, 2023 (view filing) | Oct 4 | 2 days | Musket David BDirector | PPurchase | +2.50K | $2.90 | +$7.25K | +10.6%26.0K after | |
| Apr 27, 2023 (view filing) | Apr 17 | 10 daysLate | Avat XavierOther: Former CBO | SSale | −14.8K | $64,258.00 | −$949.2M | −100.0%0 after | Price outlier |
| Apr 7, 2023 (view filing) | Mar 28 | 10 daysLate | Avat XavierOther: FORMER CHIEF BUSINESS OFFICER | SSale | −3.00K | $4.06 | −$12.2K | −100.0%0 after | |
| Jul 7, 2022 (view filing) | Jun 29-Jul 6 | 8 daysLate | Avat XavierCHIEF BUSINESS OFFICER | PPurchase | +2.50K | $3.73 | +$9.32K | +500.0%3.00K after | 2 lots |
| Jul 1, 2022 (view filing) | Jun 29 | 2 days | Musket David BDirector | SSale | −28.2K | $3.77 | −$106.4K | −68.9%12.7K after | |
| Jun 29, 2022 (view filing) | Jun 27 | 2 days | Musket David BDirector | SSale | −17.8K | $4.44 | −$78.9K | −30.3%41.0K after |